Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1361-1370 of 1,873) with videos related to

Pageof 188
Sort By:
JACC. Heart Failure|May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF StudyVanessa Blumer, James L Januzzi, Yuxi Liu, et al.
European Heart Journal|May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsAkshay S Desai, John J V McMurray, Milton Packer, et al.
Blood|August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphomaM J Stone, E A Sausville, J W Fay, et al.
ESC Heart Failure|April 15, 2023
Optimizing outcomes in heart failure: 2022 and beyondEwa A Jankowska, Tomas Andersson, Claudia Kaiser-Albers, et al.
International Journal of Cardiology|April 29, 2023
Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohortAndrew P Ambrosy, Alan S Go, Thomas K Leong, et al.
Circulation|November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and AlbuminuriaBrendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
JACC. Heart Failure|July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF TrialScott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal|August 27, 2021
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HFJames P Curtain, Kieran F Docherty, Pardeep S Jhund, et al.
Journal of Cardiac Failure|November 27, 2024
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
European Journal of Heart Failure|June 27, 2023
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Pageof 188

Showing results (1361-1370 of 1,873) with videos related to

Sort By:
Pageof 188
JACC. Heart Failure|May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF StudyVanessa Blumer, James L Januzzi, Yuxi Liu, et al.
European Heart Journal|May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsAkshay S Desai, John J V McMurray, Milton Packer, et al.
Blood|August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphomaM J Stone, E A Sausville, J W Fay, et al.
ESC Heart Failure|April 15, 2023
Optimizing outcomes in heart failure: 2022 and beyondEwa A Jankowska, Tomas Andersson, Claudia Kaiser-Albers, et al.
International Journal of Cardiology|April 29, 2023
Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohortAndrew P Ambrosy, Alan S Go, Thomas K Leong, et al.
Circulation|November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and AlbuminuriaBrendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
JACC. Heart Failure|July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF TrialScott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal|August 27, 2021
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HFJames P Curtain, Kieran F Docherty, Pardeep S Jhund, et al.
Journal of Cardiac Failure|November 27, 2024
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
European Journal of Heart Failure|June 27, 2023
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Pageof 188